| Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans G Galletti, G De Simone, EMC Mazza, S Puccio, C Mezzanotte, TM Bi, ... Nature Immunology 21 (12), 1552-1562, 2020 | 191 | 2020 |
| Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity B Prinzing, CC Zebley, CT Petersen, Y Fan, AA Anido, Z Yi, P Nguyen, ... Science translational medicine 13 (620), eabh0272, 2021 | 149 | 2021 |
| MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects V Verma, N Jafarzadeh, S Boi, S Kundu, Z Jiang, Y Fan, J Lopez, ... Nature Immunology 22 (1), 53-66, 2021 | 119 | 2021 |
| Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes HA Abdelsamed, CC Zebley, H Nguyen, RL Rutishauser, Y Fan, ... Nature Immunology 21 (5), 578-587, 2020 | 80 | 2020 |
| Stem, Effector, and Hybrid States of Memory CD8+ T Cells E Lugli, G Galletti, SK Boi, BA Youngblood Trends in Immunology 41 (1), 17-28, 2020 | 76 | 2020 |
| Obesity alters immune and metabolic profiles: New insight from obese‐resistant mice on high‐fat diet SK Boi, CM Buchta, NA Pearson, MB Francis, DK Meyerholz, JL Grobe, ... Obesity 24 (10), 2140-2149, 2016 | 72 | 2016 |
| Obesity diminishes response to PD-1-based immunotherapies in renal cancer SK Boi, RM Orlandella, JT Gibson, WJ Turbitt, G Wald, L Thomas, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 61 | 2020 |
| CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia CC Zebley, C Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ... Cell reports 37 (9), 2021 | 54 | 2021 |
| Modulation of the IL-6 receptor α underlies GLI2-mediated regulation of Ig secretion in Waldenström macroglobulinemia cells DA Jackson, TD Smith, N Amarsaikhan, W Han, MS Neil, SK Boi, ... The Journal of Immunology 195 (6), 2908-2916, 2015 | 24 | 2015 |
| Epigenetic regulation of T cell adaptive immunity AB Frias, SK Boi, X Lan, B Youngblood Immunological Reviews 300 (1), 9-21, 2021 | 21 | 2021 |
| The antidiabetic agent acarbose improves anti-PD-1 and rapamycin efficacy in preclinical renal cancer RM Orlandella, WJ Turbitt, JT Gibson, SK Boi, P Li, DL Smith Jr, LA Norian Cancers 12 (10), 2872, 2020 | 17* | 2020 |
| Obesity as defined by waist circumference but not body mass index is associated with higher renal mass complexity LA Bertrand, LJ Thomas, P Li, CM Buchta, SK Boi, RM Orlandella, ... Urologic Oncology: Seminars and Original Investigations 35 (11), 661. e1-661. e6, 2017 | 16 | 2017 |
| Epigenetic regulation of toll-like receptor signaling: Implications for cancer development SK Boi, SF Elsawa Medical Epigenetics 1 (1), 19-30, 2013 | 9 | 2013 |
| BATF targets T cell exhaustion for termination SK Boi, X Lan, B Youngblood Nature Immunology 22 (8), 936-938, 2021 | 7 | 2021 |
| Antigen cross-presentation in young tumor-bearing hosts promotes CD8+ T cell terminal differentiation A Moustaki, JC Crawford, S Alli, Y Fan, S Boi, AE Zamora, ... Science Immunology 7 (68), eabf6136, 2022 | 5 | 2022 |
| Obesity induces limited changes to systemic and local immune profiles in treatment-naive human clear cell renal cell carcinoma JT Gibson, KE Norris, G Wald, CM Buchta Rosean, LJ Thomas, SK Boi, ... Plos one 15 (5), e0233795, 2020 | 4 | 2020 |
| Lentiviral gene therapy with low dose busulfan for infants with X-SCID results in the development of a functional normal immune system: interim results of an ongoing phase I/II … E Mamcarz, S Zhou, T Lockey, S Boi, Y Koon-Kiu, S Cross, G Kang, Z Ma, ... Blood 134, 2058, 2019 | 4 | 2019 |
| Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects CM Buchta, SK Boi, BJ Miller, MM Milhem, LA Norian ImmunoHorizons 1 (4), 20-28, 2017 | 4 | 2017 |
| Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor … WJ Turbitt, SK Boi, JT Gibson, RM Orlandella, LA Norian Cancers 13 (10), 2295, 2021 | 2 | 2021 |
| The Transcription Factor GLI3 Is a Novel Candidate Effector Of Toll-Like Receptor 4 (TLR4) Signaling In Monocytes SK Boi, ME Fernandez-Zapico, SF Elsawa Blood 122 (21), 2269, 2013 | 2 | 2013 |
